This inventor holds 2 USPTO granted patents. Top assignees: Kanebo, Limited, University of Pittsburgh. Active years: 1990-2000.
Company Filing History:
Years Active: 1990-2000
Title: Masami Ohashi: Innovator in Cancer Treatment
Introduction
Masami Ohashi is a notable inventor based in Ibaraki, Japan. She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 2 patents, her work focuses on utilizing novel compounds to improve health outcomes for patients.
Latest Patents
Ohashi's latest patents include groundbreaking methods for reducing tumor colony numbers. One of her inventions pertains to treating cancer by employing benzothiazole activated natural killer cells and interleukin-2. This method aims to decrease tumor colony numbers in a mammalian host, showcasing her commitment to advancing cancer therapies. Another patent involves a benzothiazole compound that is effective in treating rheumatic arthritis, highlighting her versatility in addressing various health issues.
Career Highlights
Throughout her career, Masami Ohashi has worked with esteemed institutions such as the University of Pittsburgh and Kanebo, Limited. Her experience in these organizations has allowed her to collaborate with leading experts in her field and contribute to significant advancements in medical research.
Collaborations
Ohashi has collaborated with notable individuals, including Kohichiro Yoshino and Ronald H. Goldfarb. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Masami Ohashi's innovative work in cancer treatment and her contributions to medical research underscore her importance as an inventor. Her patents reflect a dedication to improving patient care and advancing scientific knowledge.